Clinical trials
Terminated Phase 2 Brain Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 6 |
| 2008 | 10 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 7 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 91 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| Duke University | 4 |
| Alliance for Clinical Trials in Oncology | 3 |
| Case Comprehensive Cancer Center | 2 |
| GlaxoSmithKline | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Liza Villaruz, MD | 2 |
| M.D. Anderson Cancer Center | 2 |
| Merck Sharp & Dohme LLC | 2 |
| OHSU Knight Cancer Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Neoplasms | 91 |
| Glioblastoma | 24 |
| Glioma | 15 |
| Neoplasm Metastasis | 15 |
| Melanoma | 13 |
| Gliosarcoma | 12 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Astrocytoma | 9 |
| Breast Neoplasms | 9 |
| Lung Neoplasms | 7 |
Trials
Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.